2016 Press Releases

Webcast ImageWebcast
Kindred Biosciences' Second Quarter 2018 Financial Results (Replay)
08/09/18 at 4:30 p.m. ET
Kindred Biosciences' Second Quarter 2018 Financial Results
Thursday, August 9, 2018 4:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014

Kindred Biosciences to Present Zimeta Pivotal Data at the 62nd Annual American Association of Equine Practitioners Convention

November 29, 2016

SAN FRANCISCO, Nov. 29, 2016 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ... 

Kindred Biosciences to Present at 9th Annual LD Micro Investor Conference

November 18, 2016

SAN FRANCISCO, Nov. 18, 2016 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ... 

Kindred Biosciences Announces Third Quarter 2016 Financial Results

November 7, 2016

SAN FRANCISCO, Nov. 7, 2016 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K... 

Kindred Biosciences to Announce Third Quarter 2016 Financial Results

October 24, 2016

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m... 

Kindred Biosciences Receives Approval of Effectiveness Technical Section from FDA for Zimeta New Animal Drug Application

October 4, 2016

SAN FRANCISCO, Oct. 4, 2016 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K... 

Kindred Biosciences Submits Final Major New Animal Drug Application Technical Section for Safety for Mirataz to FDA and Launches KindredBio Equine Website

September 30, 2016

SAN FRANCISCO, Sept. 30, 2016 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ:... 

Kindred Biosciences to Present at 2016 Ladenburg Thalmann Healthcare Conference

September 20, 2016

SAN FRANCISCO, Sept. 20, 2016 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ:... 

Kindred Biosciences to Participate in a BIO Animal Biotech Summit Panel

September 15, 2016

SAN FRANCISCO, Sept. 15, 2016 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ:... 

Kindred Biosciences Submits New Animal Drug Application Technical Section for Effectiveness for Mirataz to FDA

August 22, 2016

SAN FRANCISCO, Aug. 22, 2016 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ... 

Kindred Biosciences Announces Second Quarter 2016 Financial Results

August 8, 2016

SAN FRANCISCO, Aug. 8, 2016 /PRNewswire/ -- Kindred Biosciences, Inc. (NASD... 

Kindred Biosciences to Announce Second Quarter 2016 Financial Results

July 26, 2016

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m... 

Kindred Biosciences Announces Initiation of Pilot Field Study of Atopic Dermatitis and Other Updates

June 14, 2016

SAN FRANCISCO, June 14, 2016 /PRNewswire/ -- Kindred Biosciences, Inc. (NAS... 

Kindred Biosciences Announces HITS Sponsorship

May 25, 2016

SAN FRANCISCO, May 25, 2016 /PRNewswire/ -- Kindred Biosciences, Inc. (NASD... 

Kindred Biosciences Announces Positive Results from Pivotal Study of KIND-010 for the Management of Weight Loss in Cats

May 16, 2016

SAN FRANCISCO, May 16, 2016 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ... 

Kindred Biosciences Announces First Quarter 2016 Financial Results

May 5, 2016

SAN FRANCISCO, May 5, 2016 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDA... 

Kindred Biosciences Submits KIND-010 New Animal Drug Application Technical Section for Chemistry, Manufacturing, and Controls to FDA

May 4, 2016

SAN FRANCISCO, May 4, 2016 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDA... 

Kindred Biosciences to Announce First Quarter 2016 Financial Results

April 25, 2016

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m... 

Kindred Biosciences Elects Herbert D. Montgomery to Join Its Board of Directors

April 15, 2016

Highly Experienced Finance Executive to Join KindredBio's Board ... 

Kindred Biosciences Submits Final Major New Animal Drug Application Technical Section for Safety for Zimeta to FDA

March 15, 2016

SAN FRANCISCO, March 15, 2016 /PRNewswire/ -- Kindred Biosciences, Inc. (NA... 

Kindred Biosciences Announces Fourth Quarter and Year-End 2015 Financial Results

March 2, 2016

SAN FRANCISCO, March 2, 2016 /PRNewswire/ -- Kindred Biosciences, Inc. (NAS... 

Kindred Biosciences to Announce Fourth Quarter and Year-End 2015 Financial Results

February 25, 2016

SAN FRANCISCO, Feb. 25, 2016 /PRNewswire/ -- Kindred Biosciences, Inc. (NAS... 

Kindred Biosciences Submits Zimeta (KIND-012) New Animal Drug Application Technical Section for Effectiveness to FDA

February 11, 2016

SAN FRANCISCO, Feb. 11, 2016 /PRNewswire/ -- Kindred Biosciences, Inc. (NAS... 

Kindred Biosciences Releases Positive Results of Pilot Field Study of KIND-010 for the Management of Weight in Cats

January 26, 2016

SAN FRANCISCO, Jan. 26, 2016 /PRNewswire/ -- Kindred Biosciences, Inc. (NAS... 

Kindred Biosciences to Provide Corporate Update

January 7, 2016

SAN FRANCISCO, Jan. 7, 2016 /PRNewswire/ -- Kindred Biosciences, Inc. (NASD...